SEOUL, Dec. 5 (Korea Bizwire) — South Korean researchers have discovered that oats can be effective in preventing and treating dementia. The Rural Development Administration (RDA) and Chonnam National University, in a joint experiment, fed a rat with Alzheimer’s disease an Avenanthramide C (Avn-C), substance found in oats, for two weeks. The results showed the [...]
RENSSELAER, N.Y., Nov. 4 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests [...]
Toronto, Canada, Jun. 4 (Korea Bizwire) – Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study involving 228 subjects with moderate to severe cognitive impairment due to Alzheimer’s Disease. [...]
SEOUL, Mar. 14 (Korea Bizwire) — Experts are calling for guardianship programs that can support the decision-making process of seniors with Alzheimer’s disease and persons with developmental or mental disabilities. At a seminar held on Wednesday at the National Assembly to discuss the introduction of a new law that will govern various forms of assistance [...]
SEOUL, Mar. 12 (Korea Bizwire) — Statistics Korea has revealed that the cost of hiring caregivers rose by 6.9 percent last year, the largest jump since 2005. Last year’s overall consumer price index only rose by 1.5 percent. The only other time that the cost of caregivers has jumped as much was in 2008, when [...]
GERMANTOWN, Md., Oct. 25 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, announced the publication of a manuscript in Scientific Reports showing that transplantation of NSI-532.IGF1, a proprietary human neural stem cell line developed by Neuralstem (US patent no 9,750,769), mitigates disease pathology and improves [...]
GERMANTOWN, Md., Jul. 23 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the presentation of data at the Alzheimer’s Association International Conference in Chicago, Illinois, demonstrating that oral administration of NSI-189 in a mouse model of Alzheimer’s Disease leads to a significant amelioration and/or improvement [...]
SEOUL, Jul. 11 (Korea Bizwire) — A new study has found that people who consume ginseng on a regular basis have better cognitive abilities than those who do not. A medical research team at the Seoul National Unversity Bundang Hospital led by Prof. Kim Gi-ung revealed yesterday that the team had observed 6,422 senior citizens [...]
SEOUL, Jun. 23 (Korea Bizwire) — Novel Alzheimer’s disease (AD) medication developed by Megabiowood research team is planning for phase I clinical trial in next year. The novel medication is appraised to have high commercial possibilities as its aspects which shows non-cytotoxicity and superior absorbency that solves not only the symptoms but also the cause [...]
SEOUL, Jun. 12 (Korea Bizwire) — A new study has revealed that middle-aged adults who go under general anesthesia are 29 percent more likely to suffer from Alzheimer’s disease than those who don’t. Although patients should not be afraid of going under general anesthesia, the study suggests that a patient’s cognitive performance should be checked [...]